GLP-1 Side Effects: The Real Rates, Timeline, and How to Manage Them

GLP-1 side effects at a glance

Most side effects are gastrointestinal, dose-related, and worst when you first start or step up a dose. Here are the rates from the Wegovy (semaglutide 2.4 mg) label, next to placebo — the gap between the two columns is what the drug actually adds.

One thing to hold onto before we go symptom by symptom: gut side effects reach roughly 40–70% of patients, but most are mild to moderate, and only a small share of people stop treatment because of them (FDA Zepbound label).

The gut side effects (the common ones)

Nausea

Nausea is the number-one complaint: 44% on Wegovy versus 16% on placebo. On Zepbound it climbs with the dose — 25% at 5 mg, 29% at 10 mg (FDA). It’s usually worst in the first few days after a dose change and then fades. Eating slowly, keeping meals small and low-fat, and not lying down straight after eating all help.

Diarrhea

About 30% of Wegovy users report diarrhea (FDA), and real-world data lands close, around a third of patients (real-world GLP-1 analysis). It tends to be loose stools rather than dramatic urgency. Stay hydrated, add soluble fiber, and flag it if it’s frequent or won’t settle — persistent diarrhea can tip into dehydration.

Constipation

The flip side, and common too: 24% on Wegovy, 17% on Zepbound at 5 mg. Slowed gut movement plus eating less means things back up. Fiber, fluids, and movement are the first fixes; a gentle laxative if your prescriber okays it.

Vomiting, bloating, and the burping

Vomiting affects 24% on Wegovy (vs 6% placebo), usually alongside nausea after a dose increase. Plenty of people also notice more burping, bloating, and reflux. Smaller meals and going easy on greasy, sugary, and fizzy foods take the edge off.

Why the gut takes the hit

GLP-1 drugs slow how fast your stomach empties — that’s part of how they curb appetite. Food sits longer, so fullness, nausea, and irregular bowel movements follow (Cleveland Clinic). It also explains why raising the dose briefly brings the symptoms back: your gut has to re-adapt.

Headache and fatigue

Beyond the gut, headache (14% vs 10%) and fatigue (11% vs 5%) show up on the Wegovy label (FDA). Both often trace back to the same cause: when nausea kills your appetite, you eat and drink less, and dehydration plus low intake leaves you headachy and drained. The fix is usually boring but real — water, some salt, and regular small meals even when you don’t feel like it.

Does GLP-1 cause hair loss?

It can, but it’s uncommon and usually temporary. Hair loss was reported in about 3% of Wegovy users (vs 1% placebo) and around 5% on Zepbound — and it hits women far more than men (7.1% vs 0.5% on Zepbound) (FDA).

Practically: enough protein, iron and vitamin D if you’re low, and patience — the shedding usually starts 1–6 months in and reverses. Losing weight a bit more gradually can blunt it.

Muscle loss — and how to protect it

This one gets too little attention. When you lose weight on a GLP-1, not all of it is fat. In the STEP 1 trial, participants lost about 15% of body weight — but roughly a quarter of the weight lost was lean (muscle) mass (STEP 1, NEJM). That’s normal for any major weight loss, but muscle is worth defending — it protects strength, metabolism, and long-term results.

Two things have real evidence behind them:

• Protein: aim for at least ~1.2 g per kg of body weight per day (roughly 25–30 g per meal) — harder than it sounds when your appetite is suppressed, which is exactly why it needs planning.
• Resistance training: two to three sessions a week of strength work is the single best signal to your body to keep muscle while it drops fat.

Drug effect vs. rapid weight loss — which is which?

It helps to sort side effects into two buckets, because the fixes differ:

The first bucket eases with titration and diet tweaks. The second eases by losing weight at a sensible pace and protecting muscle and nutrition along the way — not by stopping the drug.

How dose and drug change the odds

Side effects are dose-related, so they climb as you titrate up. On Zepbound, the label lays it out clearly (FDA):

The drug you’re on matters too — but be careful comparing numbers across labels. Wegovy and Zepbound are studied at high doses in people with obesity, while Ozempic and Mounjaro are the type-2-diabetes versions, often used at lower doses in a different population. That’s a big reason their published rates look different, and why “which GLP-1 has the fewest side effects” has no clean answer. Compare the rates within a label as you go up in dose, not across two different labels.

Other effects worth knowing

• Injection-site reactions: mild redness or itching where you inject, in roughly 6–8% of people at higher Zepbound doses (FDA). Rotating sites helps.
• Low blood sugar: uncommon on a GLP-1 alone, but the risk rises if you also take insulin or a sulfonylurea — your prescriber may lower those doses.
• Gallstones: more likely with rapid weight loss of any kind; watch for the gallbladder red flags below.
• A small bump in heart rate: a modest resting-heart-rate rise is seen with this class (Cleveland Clinic).

How long do GLP-1 side effects last?

This is the question the app was built for, because the honest answer is “it depends — but there’s a pattern.” For the gut side effects, clinicians describe a fairly consistent arc (Cleveland Clinic):

• Peak: within days of starting or raising a dose.
• Ease: over the following 1–2 weeks as your gut adapts.
• Settle: largely resolved within about 1–3 months at a steady dose.
• Recur: a brief flare at each dose increase, then the same fade.

That pattern is why tracking beats guessing. A symptom that’s milder each day is following the normal curve; one that’s getting worse a week in, or is severe, is worth a call — and you’ll only know which you’re on if you’ve been writing it down.

How to reduce and manage the side effects

None of this replaces your prescriber, but these are the evidence-backed basics (Cleveland Clinic):

If the basics aren’t cutting it, don’t just tough it out — and don’t quietly quit either. Ask your prescriber. The usual moves are to hold at your current dose longer before the next step up, drop back a level, or add a short course of an anti-nausea medicine. Most side effects are a titration problem, not a reason to give up on the drug — but that’s a conversation to have out loud, with the log to back it up, rather than a decision to make alone at 2 a.m.

Serious side effects & red flags

The common effects are a nuisance. These are not — treat them as reasons to call your doctor now, or get urgent care (FDA Wegovy label):

One more, for context rather than alarm: GLP-1 drugs carry a boxed warning about thyroid C-cell tumors seen in rodents. It hasn’t been confirmed in people, but they’re not for anyone with a personal or family history of medullary thyroid cancer or MEN 2 (FDA).

What to track (and bring to your doctor)

Side effects are a moving target, and your memory is a bad witness at the next appointment. The people who manage this well keep a simple log:

• Your dose and the date of each change
• Each symptom, with a 1–5 severity score and the date
• Weight over time
• Anything that helped or made it worse

That’s the honest reason I built a GLP-1 tracker that lets you log your dose, weight, and side effects in one place and export a clean summary for your prescriber. It won’t treat anything or give advice — it just turns “I think it’s getting better?” into a line you can actually read. If you’re on a GLP-1 for a specific condition, it pairs with our guide to GLP-1 for sleep apnea.

Frequently asked questions

What are the most common GLP-1 side effects?

Gastrointestinal effects are by far the most common — nausea, diarrhea, vomiting, and constipation. Nausea alone affects up to 44% of Wegovy users.

How long do GLP-1 side effects last?

They usually peak within days of starting or raising a dose, ease over 1–2 weeks, and largely settle within 1–3 months as your body adapts. They can briefly return at each dose increase.

Does GLP-1 cause hair loss?

It’s an uncommon labeled effect (about 3% on Wegovy, ~5% on Zepbound) tied to rapid weight loss rather than the drug itself, it affects women more than men, and it’s usually temporary.

Why does GLP-1 cause diarrhea?

These drugs change how fast the gut moves. Diarrhea occurred in about 30% of Wegovy users in trials and roughly a third of patients in real-world data.

Do GLP-1s cause muscle loss?

Some of the weight lost is muscle — studies suggest roughly a quarter of it. Eating enough protein and doing resistance training helps protect lean mass.

Can GLP-1s cause headaches?

Yes — headache was reported in 14% of Wegovy users versus 10% on placebo, often linked to dehydration or eating too little while nauseated.

How do I stop GLP-1 nausea?

Slow dose increases plus smaller, more frequent low-fat meals, eating slowly, and staying hydrated. If it’s severe or won’t settle, talk to your prescriber about the titration pace.

Which GLP-1 has the fewest side effects?

Rates differ by drug and dose, and the trial populations differ, so compare the labels rather than assume. Nausea, for example, is far more common at higher doses.

When are GLP-1 side effects an emergency?

Severe abdominal pain that spreads to your back, relentless vomiting, jaundice, or signs of a severe allergic reaction. These need urgent care, not a wait-and-see.

Do side effects come back when the dose goes up?

Often, briefly. Because they’re dose-related, symptoms can flare for a few days after each increase, then ease again as your gut adapts.

Does everyone get GLP-1 side effects?

No. Gut side effects hit roughly 40–70% of patients, most are mild to moderate, and only a small share of people stop treatment because of them.

The bottom line

Most GLP-1 side effects are gut-related, dose-related, and temporary — nausea, diarrhea, constipation — worst at the start and after each increase, and usually settling within a few months. Hair and muscle loss come from the weight loss itself and can be blunted with protein, strength work, and a sensible pace. A handful of symptoms are genuine red flags. Know which bucket yours is in, manage the common ones, track the trend, and keep the serious ones on your doctor’s radar.

This article is general information, not medical advice. Talk to a qualified clinician before starting, stopping, or changing any medication. Rates cited are from FDA prescribing information; Wegovy and Zepbound figures come from obesity trials and may differ from the diabetes versions of these drugs.